SFJ Pharmaceuticals

Eisai readies applications for thyroid cancer drug after SFJ delivers PhIII success
Fierce Biotech
Tue, 02/4/14 - 07:05 pm
Eisai
Lenvatinib
thyroid cancer
SFJ Pharmaceuticals